Back to Results
First PageMeta Content
Beta-glucan / Gums / Polysaccharides / Oat / Risk / Liquidity risk / Strategic management / Market liquidity / Finance / Food and drink / Management / Financial markets


● ● ● ● Table of contents Letter to Shareholders
Add to Reading List

Document Date: 2013-06-12 10:46:03

Open Document

File Size: 2,74 MB

Share Result on Facebook

City

Edmonton / Leduc / /

Company

Ceapro USA Inc. / Ceapro Technology Inc. / Ceapro Veterinary Products Inc. / Ceapro BioEnergy Inc. / Ceapro Active Ingredients Inc. / Ceapro Inc. / Alberta Innovates Bio Solutions / Agriculture Financial Services Corporation / CGA / /

Continent

Asia / North America / Europe / /

Country

Japan / United States / Canada / Australia / /

Currency

USD / /

Event

Business Partnership / Funding / Reorganization / /

Facility

Ceapro’s facility / New Manufacturing Facility / Leduc facility / National Research Council Institute / /

IndustryTerm

cosmetics applications / stage biotechnology / biotechnology / manufacturing options / extraction technology / liquid solution / manufacturing technologies / beta glucan technology / natural products / value proprietary therapeutic natural products / wound healing products / higher purity products / anti-aging products / therapeutic food / avenanthramide-rich oat products / food / mild processing / quality product / bank accounts / pharmaceuticals / active pharmaceutical ingredient / therapeutics products / pharmaceutical markets / bio-industrial processing today / functional food / manufacturing infrastructure / plant extract products / generation products / contract manufacturing scenarios / technology / active natural products / technology advancements / supercritical fluid drying technology / manufacturing areas / technology platforms / manufacturing / therapeutic products / potential products / oat oil / natural health solutions / suitable solution / /

MedicalCondition

chicken pox / joint inflammation / colon cancer / metabolic diseases / atherosclerosis / eczema / diabetes / high cholesterol / metabolic disease / inflammatory bowel syndrome / /

NaturalFeature

Edward Island / /

Organization

Bio-Industrial Centre of Excellence / Government of Alberta / National Research Council Institute for Nutrisciences and Health / Nuclear Regulatory Commission / MBA / /

Person

ED TAYLOR / GILLES R. GAGNON / /

Position

leader / PRESIDENT AND CEO / General business risks / CHAIRMAN OF THE BOARD / /

Product

INH / /

ProvinceOrState

Alberta / Prince Edward Island / Nevada / /

Technology

beta glucan technology / biotechnology / API / nutraceuticals / drug delivery / improving manufacturing technologies / bioprocessing / two technologies / supercritical fluid drying technology / extraction technology / /

URL

www.sedar.com / /

SocialTag